Jul 18, 2025
The treatment options for spinal cord injury remain limited, with few approved spinal cord injury therapies available. At present, STEMIRAC is the only approved SCI treatment, and it is offered exclusively in Japan. There is an urgent need for targeted solutions that can enhance patient outcomes and support functio...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper